Research Type: Business and Popular Press

Our expertise and opinions regarding drug pricing and development are sought by journalists for both Business and Popular Press. Our editorial writings, often in collaboration with other experts, allows us to comment in a broader forum.

  • Battle Lines Drawn Over Medicare Pricing Proposal

  • Medicare Looks to Cut Drug Costs By Changing How It Pays Doctors

  • Medicare Considers Overhaul of Doctors’ Payments for Drugs

  • Solving Pharma’s Shkreli Problem

  • The Big Problem With High Health Care Deductibles

  • Rising Drug Costs Only Getting Worse

  • Patients Struggle With High Drug Prices

  • Express Scripts Turns to a Compounder to Avoid a Turing Drug

  • The FDA May No Longer Exist in 25 Years- Here’s Why

  • How Doctors Can Pressure Drug Companies to Lower Prices